Moneycontrol
Get App
SENSEX NIFTY
you are here:

Ajanta Pharma Ltd.

BSE: 532331 | NSE: AJANTPHARM |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE031B01049 | SECTOR: Pharmaceuticals

Success
Alert
Please select a Day.
Info

BSE Live

Feb 25, 16:00
1421.35 11.20 (0.79%)
Volume
AVERAGE VOLUME
5-Day
15,181
10-Day
18,959
30-Day
10,597
9,775
  • Prev. Close

    1410.15

  • Open Price

    1422.00

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

NSE Live

Feb 25, 15:56
1419.75 6.65 (0.47%)
Volume
AVERAGE VOLUME
5-Day
325,605
10-Day
303,909
30-Day
237,128
174,132
  • Prev. Close

    1413.10

  • Open Price

    1413.35

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

ANNOUNCEMENTS ON Ajanta Pharma

  • Feb 24, 2020 16:00 Source: BSE

    Ajanta Pharma - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.

    The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on February 24, 2020 for Aayush M Agrawal, Trustee Aayush Agrawal Trust

  • Feb 24, 2020 9:58 Source: BSE

    Ajanta Pharma - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

    The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on February 24, 2020 for Aayush Agrawal

  • Feb 17, 2020 13:57 Source: BSE

    Ajanta Pharma - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

    Intimation of Issue of Duplicate Share Certificates under Regulation 39(3) of SEBI (LODR) Regulations, 2015.

  • Feb 06, 2020 14:15 Source: BSE

    Ajanta Pharma - Announcement under Regulation 30 (LODR)-Newspaper Publication

    Pursuant to Regulation 47 of the Listing Regulations, please find enclosed copies of financial results of the Company for the third quarter ended 3lst December 2019 published in the following newspapers on 6th February 2020: l. Mumbai edition of Economic Times and 2. Mumbai edition of Maharashtra Times 3. Mumbai edition of Lokmat This is for your information and record.

  • Feb 05, 2020 18:05 Source: BSE

    Ajanta Pharma - Announcement under Regulation 30 (LODR)-Investor Presentation

    Presentation on results

  • Feb 05, 2020 17:58 Source: BSE

    Ajanta Pharma - Outcome Of Board Meeting Q3 FY 2020

    Please find enclosed herewith following: i. Press Release being issued on the Results for the third quarter ended 31st December 2019; ii. Unaudited Consolidated Financial Results for the third quarter ended 31st December 2019; iii. Limited Review Report from Auditors M/s B S R & Co. LLP on the unaudited Consolidated Financial Results for the third quarter ended 31st December 2019; iv. Unaudited Standalone Financial Results for the third quarter ended 31st December 2019; v. Limited Review Report from Auditors M/s B S R & Co. LLP on the unaudited Standalone Financial Results for the third quarter ended 31st December 2019. Kindly note that the meeting of the Board of Directors commenced at 3.30 p.m. and concluded at 5.45 p.m.

  • Jan 27, 2020 14:03 Source: BSE

    Ajanta Pharma - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

    We have been informed by the shareholder about the loss /misplacement of the share certificate as per attachment. We request you to kindly take the above on record.

  • Jan 21, 2020 14:47 Source: BSE

    Ajanta Pharma - Announcement under Regulation 30 (LODR)-Newspaper Publication

    Pursuant to Regulation 47 of the Listing Regulations, please find enclosed intimation about the meeting of Board of Directors of the Company to be held on Wednesday, 5th February 2020 published in the following newspapers on 21st January 2020: 1. Mumbai edition of The Free Press Journal and 2. Mumbai edition of Navshakti; This is for your information and record.

  • Jan 20, 2020 11:00 Source: BSE

    Ajanta Pharma - Board Meeting Intimation for Board Meeting Intimation For Quarterly Results.

    AJANTA PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/02/2020 ,inter alia, to consider and approve Pursuant to Regulation 29 of the Listing Regulations, we hereby inform that a Meeting of the Board of Directors of the Company will be held on Wednesday, 5th February 2020 in Mumbai to inter-alia consider and approve unaudited consolidated and standalone financial results of the Company for the third quarter ended 3lst December 2019. Kindly take note of the same and inform your members suitably.

  • Jan 09, 2020 17:01 Source: NSE

    Ajanta Pharma Limited

    Ajanta Pharma Limited has informed the Exchange regarding ''Pleased find enclosed herewith certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 31st December 2019 received from M/s. Link Intime India Private Limited, Registrar and Share Transfer Agent of the Company. ''.

CORPORATE ANNOUNCEMENTS

BOARD MEETING

Meeting Date : Feb 05, 2020
Remark : Quarterly Results